FDA data Registry peer set 1 peer FDA shortage listed

Alternatives to propranolol

FDA shortage status is active for propranolol; 1 same-class SPL records are listed below for registry comparison only.

Brand: Inderal

Non-Selective Beta-Blocker Prescription 1 alternative found

propranolol class peers while FDA lists an active shortage

propranolol (Inderal) is on an FDA shortage listing while 1 other Non-Selective Beta-Blocker SPL records remain in this registry peer set (class inventory 2). Labeled indication field for propranolol: Propranolol tablets can treat high blood pressure.

Top FAERS reaction fields for propranolol total 30,035 reports across 10 reactions, set beside nadolol. Counts are exposure-weighted submissions, not per-patient risk.

About propranolol

Propranolol is a medicine that can help with high blood pressure, chest pain, and other conditions. It works by blocking the effects of certain natural chemicals in your body, like adrenaline, that affect the heart and blood vessels.

Used for: Propranolol tablets can treat high blood pressure. It can be used alone or with other medicines. Propranolol can also help with chest pain (angina), control fast heart rate with atrial fibrillation, improve survival after a heart attack, prevent migraine headaches, and reduce tremors. It can also help with symptoms of some tumors.

1 Non-Selective Beta-Blocker peers (wide set)

Compare propranolol vs nadolol side-by-side →

propranolol vs nadolol · FAERS reaction fields

FAERS top-reaction field "Nausea" shows the widest count spread between propranolol and nadolol in this extract (3,616-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect propranolol nadolol
Nausea 4,279 663
Headache 3,785 588
Fatigue 3,752 522
Diarrhoea 3,119 433
Dizziness 3,102 333
Vomiting 2,650 -
Dyspnoea 2,561 319
Pain 2,324 502

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

propranolol shortage vs Non-Selective Beta-Blocker peer index

Shortage status

FDA shortage listing is active for propranolol (status: Current). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for propranolol while peers remain indexed?
Yes - propranolol matched an active FDA shortage listing (Current) while 1 other Non-Selective Beta-Blocker SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full propranolol profile →

Field note for propranolol: see also the generic vs brand label guide when reading Inderal SPL strings.